... However, the outlook for some rare kidney diseases is improving thanks to new research.Budesonide (Tarpeyo) is a drug approved by the FDA to treat the rare kidney disease immunoglobulin A nephropathy (IgAN) — also known as IgA nephropathy or Berger’s disease.Two other drugs, iptacopan (Fabhalta) and sparsentan (Filspari), were approved in 2024 for treating ...
Clinical Trials for Rare Kidney Disease: 6 Facts To Know
... However, the outlook for some rare kidney diseases is improving thanks to new research.Budesonide (Tarpeyo) is a drug approved by the FDA to treat the rare kidney disease immunoglobulin A nephropathy (IgAN) — also known as IgA nephropathy or Berger’s disease.Two other drugs, iptacopan (Fabhalta) and sparsentan (Filspari), were approved in 2024 for treating ...